Medyria

Medyria

Medyria is a Swiss medical technology pioneer specializing in invasive coronary diagnostics. The company develops blood-flow-velocity sensors and catheter technologies, with its lead product, PyCath, designed to measure blood flow velocity during interventional cardiology procedures.

Total raised
$3.9M
tracked to date
Latest round
$3.9M
Jul 24, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Switzerland.

Claim this profile →

🏆 Featured in Datapile’s Q3 2026 Switzerland Funding Report

Read the Q3 2026 Switzerland report →
Add this badge to your site
<a href="https://datapile.co/reports/q3-2026-switzerland-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 Switzerland Funding Report</a>

Funding history

  1. 1
    $3.9MJul 24, 2026
    Announcement ↗

Founder

Mauro M. Sette
Mauro M. Sette
CEO

Medyria in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile

Medyria — Health startup in Winterthur, Switzerland | Datapile